• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核糖体展示:一种用于筛选和进化具有所需特性的特异性结合分子的强大展示技术。

Ribosome Display: A Potent Display Technology used for Selecting and Evolving Specific Binders with Desired Properties.

作者信息

Li Ruowei, Kang Guangbo, Hu Min, Huang He

机构信息

Department of Biochemical Engineering, School of Chemical Engineering & Technology, Tianjin University, Tianjin, 300350, People's Republic of China.

Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300072, People's Republic of China.

出版信息

Mol Biotechnol. 2019 Jan;61(1):60-71. doi: 10.1007/s12033-018-0133-0.

DOI:10.1007/s12033-018-0133-0
PMID:30406440
Abstract

Ribosome display is a powerful engineering research tool for the high-throughput selection of peptides or proteins, which results in the generation of high-performance binders against nearly any antigen of interest. As a cell-free display system, ribosome display has been well developed with many outstanding achievements for over 20 years. Compared with other related display techniques, ribosome display shows unique advantages and development prospects. This tool has been successfully exploited for the selection of functional and specific binders in vitro. This review provides a comprehensive survey of the applications of ribosome display in screening or evolving functional proteins as well as in diagnostics and therapeutics. Previous papers on ribosome display failed to comprehensively review evolutionary strategies for proteins. In the present paper, we review all existing evolutionary strategies that have been combined with ribosome display. We also discuss shortcomings, improvement strategies, and research tendency.

摘要

核糖体展示是一种用于高通量筛选肽或蛋白质的强大工程研究工具,可产生针对几乎任何感兴趣抗原的高性能结合物。作为一种无细胞展示系统,核糖体展示在20多年来得到了很好的发展并取得了许多杰出成就。与其他相关展示技术相比,核糖体展示具有独特的优势和发展前景。该工具已成功用于体外筛选功能性和特异性结合物。本文全面综述了核糖体展示在筛选或进化功能蛋白以及诊断和治疗方面的应用。以往关于核糖体展示的论文未能全面综述蛋白质的进化策略。在本文中,我们综述了所有与核糖体展示相结合的现有进化策略。我们还讨论了缺点、改进策略和研究趋势。

相似文献

1
Ribosome Display: A Potent Display Technology used for Selecting and Evolving Specific Binders with Desired Properties.核糖体展示:一种用于筛选和进化具有所需特性的特异性结合分子的强大展示技术。
Mol Biotechnol. 2019 Jan;61(1):60-71. doi: 10.1007/s12033-018-0133-0.
2
[Ribosome display: Evolution and acellular selection of molecular libraries for high affinity binder generation].[核糖体展示:用于生成高亲和力结合剂的分子文库的进化与无细胞筛选]
Med Sci (Paris). 2020 Aug-Sep;36(8-9):717-724. doi: 10.1051/medsci/2020126. Epub 2020 Aug 21.
3
Ribosome display: a technology for selecting and evolving proteins from large libraries.核糖体展示:一种从大型文库中筛选和进化蛋白质的技术。
Methods Mol Biol. 2011;687:283-306. doi: 10.1007/978-1-60761-944-4_21.
4
Ribosome-display technology: applications for directed evolution of functional proteins.核糖体展示技术:功能性蛋白质定向进化的应用
Drug Discov Today. 2006 Oct;11(19-20):911-6. doi: 10.1016/j.drudis.2006.08.012. Epub 2006 Sep 7.
5
Evolution of protein stability using ribosome display.利用核糖体展示技术实现蛋白质稳定性的进化。
Methods Mol Biol. 2012;805:191-212. doi: 10.1007/978-1-61779-379-0_11.
6
Ribosome display with the PURE technology.采用无细胞表达系统的核糖体展示技术。 (注:PURE technology是一种无细胞表达系统,这里直接翻译可能不太好理解其完整含义,补充完整解释后方便你对照原文理解。如果仅按字面翻译是“采用PURE技术的核糖体展示” )
Methods Mol Biol. 2010;607:219-25. doi: 10.1007/978-1-60327-331-2_18.
7
Highly efficient ribosome display selection by use of purified components for in vitro translation.利用纯化成分进行体外翻译的高效核糖体展示筛选。
J Immunol Methods. 2006 Jun 30;313(1-2):140-8. doi: 10.1016/j.jim.2006.04.001. Epub 2006 May 11.
8
Ribosome display and screening for protein therapeutics.核糖体展示与蛋白质治疗药物筛选。
Methods Mol Biol. 2012;899:61-72. doi: 10.1007/978-1-61779-921-1_4.
9
The rapid discovery of engineered antibodies.工程抗体的快速发现。
IDrugs. 2007 Aug;10(8):562-5.
10
Ribosome display for improved biotherapeutic molecules.用于改进生物治疗分子的核糖体展示技术。
Expert Opin Biol Ther. 2006 Feb;6(2):177-87. doi: 10.1517/14712598.6.2.177.

引用本文的文献

1
Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization.揭开纳米抗体工程的新篇章:传统构建方法与人工智能驱动优化的进展
J Nanobiotechnology. 2025 Feb 6;23(1):87. doi: 10.1186/s12951-025-03169-5.
2
Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics.用设计肽模拟物和合成生物制剂攻克不可成药靶点。
Chem Rev. 2024 Nov 27;124(22):13020-13093. doi: 10.1021/acs.chemrev.4c00423. Epub 2024 Nov 14.
3
Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets.

本文引用的文献

1
Functional Characterization of CTX-M-14 and CTX-M-15 β-Lactamases by DNA Shuffling.通过 DNA 重排对 CTX-M-14 和 CTX-M-15β-内酰胺酶的功能特征进行分析。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.00891-17. Print 2017 Dec.
2
Site-saturation mutagenesis library construction and screening for specific broad-spectrum single-domain antibodies against multiple Cry1 toxins.用于针对多种Cry1毒素的特异性广谱单域抗体的位点饱和诱变文库构建及筛选
Appl Microbiol Biotechnol. 2017 Aug;101(15):6071-6082. doi: 10.1007/s00253-017-8347-9. Epub 2017 Jun 11.
3
Selection of single-chain variable fragments specific for ESAT-6 antigen using ribosome display.
用于不可接近药物靶点的大环肽核苷酸编码质量文库的选择。
Chem Rev. 2024 Nov 13;124(21):12213-12241. doi: 10.1021/acs.chemrev.4c00422. Epub 2024 Oct 25.
4
The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics.单链可变片段抗体的潜力:在未来治疗性和诊断性生物制剂中的作用。
J Immunol Res. 2024 Aug 9;2024:1804038. doi: 10.1155/2024/1804038. eCollection 2024.
5
A Potent Sybody Selectively Inhibits α-Synuclein Amyloid Formation by Binding to the P1 Region.一种强效的 Sybody 通过结合 P1 区域选择性地抑制α-突触核蛋白淀粉样形成。
J Med Chem. 2024 Jun 27;67(12):9857-9868. doi: 10.1021/acs.jmedchem.3c02408. Epub 2024 Jun 6.
6
Engineering the ADDobody protein scaffold for generation of high-avidity ADDomer super-binders.工程化 ADDobody 蛋白支架用于生成高亲和力的 ADDomer 超配体。
Structure. 2024 Mar 7;32(3):342-351.e6. doi: 10.1016/j.str.2023.12.010. Epub 2024 Jan 9.
7
Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics.小抗体,大应用:基于纳米抗体的癌症诊断与治疗
Cancers (Basel). 2023 Nov 29;15(23):5639. doi: 10.3390/cancers15235639.
8
Production of a Ribosome-Displayed Mouse scFv Antibody Against CD133, Analysis of Its Molecular Docking, and Molecular Dynamic Simulations of Their Interactions.核糖体展示技术筛选抗 CD133 单链抗体及其分子对接和分子动力学模拟分析
Appl Biochem Biotechnol. 2024 Mar;196(3):1399-1418. doi: 10.1007/s12010-023-04609-4. Epub 2023 Jul 6.
9
Progresses in Cell-Free In Vitro Evolution.无细胞体外进化的进展。
Adv Biochem Eng Biotechnol. 2023;186:121-140. doi: 10.1007/10_2023_219.
10
NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.NANOBODIES®:诊断和治疗应用的综述。
Int J Mol Sci. 2023 Mar 22;24(6):5994. doi: 10.3390/ijms24065994.
利用核糖体展示技术筛选针对ESAT-6抗原的单链可变片段
Iran J Basic Med Sci. 2017 Mar;20(3):327-333. doi: 10.22038/ijbms.2017.8363.
4
A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.一种新型双特异性 DARPin,靶向 FcγRIIB 和 FcεRI 结合的 IgE,抑制过敏反应。
Allergy. 2017 Aug;72(8):1174-1183. doi: 10.1111/all.13109. Epub 2017 Jan 24.
5
Interactions of in vitro selected fluorogenic peptide aptamers with calmodulin.体外筛选的荧光肽适配体与钙调蛋白的相互作用。
Biotechnol Lett. 2017 Mar;39(3):375-382. doi: 10.1007/s10529-016-2257-2. Epub 2016 Nov 17.
6
Protein Folding Activity of the Ribosome is involved in Yeast Prion Propagation.核糖体的蛋白质折叠活性参与酵母朊病毒的传播。
Sci Rep. 2016 Sep 16;6:32117. doi: 10.1038/srep32117.
7
Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit.展示抗志贺毒素1 B亚基白蛋白结合域变体的重组乳酸乳球菌的开发。
PLoS One. 2016 Sep 8;11(9):e0162625. doi: 10.1371/journal.pone.0162625. eCollection 2016.
8
Library-based display technologies: where do we stand?基于文库的展示技术:我们目前的状况如何?
Mol Biosyst. 2016 Jul 19;12(8):2342-58. doi: 10.1039/c6mb00219f.
9
Cell-free ribosome display and selection of antibodies on arrayed antigens.无细胞核糖体展示及在阵列抗原上筛选抗体
Proteomics. 2016 Apr;16(8):1291-6. doi: 10.1002/pmic.201500412. Epub 2016 Apr 4.
10
Novel Human Three-Domain Antibody Fragments Against sTNFα as Well as tmTNFα with High Affinity Generated by the Combination of Ribosome Display and E. coli Expression System.通过核糖体展示与大肠杆菌表达系统相结合产生的针对可溶性肿瘤坏死因子α(sTNFα)以及跨膜肿瘤坏死因子α(tmTNFα)的新型人三结构域抗体片段,具有高亲和力。
Scand J Immunol. 2016 Apr;83(4):267-78. doi: 10.1111/sji.12417.